Dr Swati Hasmukh Patel, MD | |
175 Madison Ave, Hospitalist Group, Mount Holly, NJ 08060-2038 | |
(609) 267-0700 | |
Not Available |
Full Name | Dr Swati Hasmukh Patel |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 17 Years |
Location | 175 Madison Ave, Mount Holly, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376855908 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Vna Of Central Jersey Home Care & Hospice | Toms river, NJ | Home health agency |
Centrastate Medical Center | Freehold, NJ | Hospital |
Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Practice Associates Medical Group | 5890703177 | 1116 |
Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.
Some of the most dangerous cancers are those that can outmaneuver the very drugs designed to defeat them, but researchers are now reporting a new Trojan-horse approach. In a preliminary study in the journal ACS Nano focusing on a type of breast cancer that is highly resistant to current therapies, they describe a way to sneak small particles into tumor cells, lower their defenses and attack them with drugs, potentially making the therapy much more effective.
To move a gene from point A to point B, scientists and gene therapists have two proven options: a virus, which can effectively ferry genes of interest into cells, and a plasmid, an engineered loop of DNA that can do the same thing, albeit usually only on a short-term basis.
People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy diagnosis.
In a Pigment Cell & Melanoma Research article, world-leading experts identify emerging frontiers in skin cancer and pigment diseases.
› Verified 7 days ago
Entity Name | Advocare Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.
Some of the most dangerous cancers are those that can outmaneuver the very drugs designed to defeat them, but researchers are now reporting a new Trojan-horse approach. In a preliminary study in the journal ACS Nano focusing on a type of breast cancer that is highly resistant to current therapies, they describe a way to sneak small particles into tumor cells, lower their defenses and attack them with drugs, potentially making the therapy much more effective.
To move a gene from point A to point B, scientists and gene therapists have two proven options: a virus, which can effectively ferry genes of interest into cells, and a plasmid, an engineered loop of DNA that can do the same thing, albeit usually only on a short-term basis.
People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy diagnosis.
In a Pigment Cell & Melanoma Research article, world-leading experts identify emerging frontiers in skin cancer and pigment diseases.
› Verified 7 days ago
Entity Name | Practice Associates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.
Some of the most dangerous cancers are those that can outmaneuver the very drugs designed to defeat them, but researchers are now reporting a new Trojan-horse approach. In a preliminary study in the journal ACS Nano focusing on a type of breast cancer that is highly resistant to current therapies, they describe a way to sneak small particles into tumor cells, lower their defenses and attack them with drugs, potentially making the therapy much more effective.
To move a gene from point A to point B, scientists and gene therapists have two proven options: a virus, which can effectively ferry genes of interest into cells, and a plasmid, an engineered loop of DNA that can do the same thing, albeit usually only on a short-term basis.
People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy diagnosis.
In a Pigment Cell & Melanoma Research article, world-leading experts identify emerging frontiers in skin cancer and pigment diseases.
› Verified 7 days ago
Entity Name | Virtua Medical Group, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.
Some of the most dangerous cancers are those that can outmaneuver the very drugs designed to defeat them, but researchers are now reporting a new Trojan-horse approach. In a preliminary study in the journal ACS Nano focusing on a type of breast cancer that is highly resistant to current therapies, they describe a way to sneak small particles into tumor cells, lower their defenses and attack them with drugs, potentially making the therapy much more effective.
To move a gene from point A to point B, scientists and gene therapists have two proven options: a virus, which can effectively ferry genes of interest into cells, and a plasmid, an engineered loop of DNA that can do the same thing, albeit usually only on a short-term basis.
People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy diagnosis.
In a Pigment Cell & Melanoma Research article, world-leading experts identify emerging frontiers in skin cancer and pigment diseases.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Swati Hasmukh Patel, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Dr Swati Hasmukh Patel, MD 175 Madison Ave, Hospitalist Group, Mount Holly, NJ 08060-2038 Ph: (609) 267-0700 |
News Archive
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.
Some of the most dangerous cancers are those that can outmaneuver the very drugs designed to defeat them, but researchers are now reporting a new Trojan-horse approach. In a preliminary study in the journal ACS Nano focusing on a type of breast cancer that is highly resistant to current therapies, they describe a way to sneak small particles into tumor cells, lower their defenses and attack them with drugs, potentially making the therapy much more effective.
To move a gene from point A to point B, scientists and gene therapists have two proven options: a virus, which can effectively ferry genes of interest into cells, and a plasmid, an engineered loop of DNA that can do the same thing, albeit usually only on a short-term basis.
People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy diagnosis.
In a Pigment Cell & Melanoma Research article, world-leading experts identify emerging frontiers in skin cancer and pigment diseases.
› Verified 7 days ago
Dr. Jubril Oyekanmi Oyeyemi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Erik Delue, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Zaheer Husain, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Pierre Rigens Valeus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-267-0700 | |
Dr. James Ward, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 | |
Brian Peng, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 |